Industry Reports |
Pharmaceuticals & Healthcare |
| No. |
Report Title |
Page |
Single User Price |
1 |
Huntington's Disease - Drug Pipeline Analysis and Market Forecasts to 2016 |
41 |
96000 |
Buy |
| 2 |
Idiopathic Pulmonary Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2016 |
53 |
96000 |
Buy |
3 |
Osteoporosis - Drug Pipeline Analysis and Market Forecasts to 2016 |
43 |
96000 |
Buy |
4 |
Chronic Kidney Disease - Drug Pipeline Analysis and Market Forecasts to 2016 |
46 |
96000 |
Buy |
5 |
Lyme Disease - Drug Pipeline Analysis and Market Forecasts to 2016 |
39 |
96000 |
Buy |
6 |
Acute Heart Failure - Drug Pipeline Analysis and Market Forecasts to 2016 |
40 |
96000 |
Buy |
| 7 |
Paget’s Disease - Drug Pipeline Analysis and Market Forecasts to 2016 |
30 |
96000 |
Buy |
8 |
Muscular Dystrophy - Drug Pipeline Analysis and Market Forecasts to 2016 |
34 |
96000 |
Buy |
9 |
Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016 |
44 |
96000 |
Buy |
10 |
Meningitis - Pipeline Analysis and Market Forecasts to 2016 |
39 |
96000 |
Buy |
11 |
Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016 |
36 |
96000 |
Buy |
| 12 |
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis |
77 |
168000 |
Buy |
| 13 |
Big Pharma's Key Lifecycle Management Strategies - Maximizing the Market Potential |
85 |
168000 |
Buy |
| 14 |
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape |
84 |
168000 |
Buy |
| 15 |
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma |
89 |
168000 |
Buy |
| 16 |
Pharmaceutical Pricing and Reimbursement - Reference Pricing and Economic Evaluations Will Dominate Future Pricing and Reimbursement Strategies |
83 |
168000 |
Buy |
| 17 |
Drug Discovery in India and China - Gaining Momentum with Increasing Pressure on Cost Cutting |
107 |
168000 |
Buy |
| 18 |
Urinary Tract Infections - Drug Pipeline Analysis and Market Forecasts to 2016 |
39 |
96000 |
Buy |
| 19 |
Periodontal Disease - Drug Pipeline Analysis and Market Forecasts to 2016 |
36 |
96000 |
Buy |
| 20 |
Liver Cancer - Drug Pipeline Analysis and Market Forecasts to 2016 |
57 |
96000 |
Buy |
| 21 |
HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016 |
69 |
96000 |
Buy |
| 22 |
Nonalcoholic Steatohepatitis - Drug Pipeline Analysis and Market Forecasts to 2016 |
54 |
96000 |
Buy |
| 23 |
The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
101 |
168000 |
Buy |
| 24 |
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways |
97 |
168000 |
Buy |
| 25 |
The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement |
128 |
168000 |
Buy |
| 26 |
The Future of eClinical Trial Solutions – Market Forecasts to 2015, Competitive Benchmarking and Case Studies |
59 |
168000 |
Buy |
| 27 |
The Future of Metabolic Disorder Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis |
148 |
168000 |
Buy |
| 28 |
The Future of the Pharmaceutical Packaging Industry - Emerging Economies Poised to Capitalize on Increasing Demand |
62 |
168000 |
Buy |
29 |
The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis |
91 |
168000 |
Buy |
| 30 |
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline |
181 |
168000 |
Buy |
| 31 |
Radio Frequency Identification (RFID) in Pharmaceuticals - Supply Chain Security Concerns Provide Impetus for RFID Adoption |
89 |
168000 |
Buy |
|
